# FRDA Investigator Initiated Study (IIS) With Elamipretide

> **NCT05168774** · PHASE1,PHASE2 · COMPLETED · sponsor: **Children's Hospital of Philadelphia** · enrollment: 20 (actual)

## Conditions studied

- Friedreich Ataxia

## Interventions

- **DRUG:** Elamipretide

## Key facts

- **NCT ID:** NCT05168774
- **Lead sponsor:** Children's Hospital of Philadelphia
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-03
- **Primary completion:** 2024-06-25
- **Final completion:** 2024-07-25
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-12-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05168774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05168774, "FRDA Investigator Initiated Study (IIS) With Elamipretide". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05168774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*